Study Evaluating Liver Transplantation in Haemophilia Patients in Spain
NCT00927992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2013-01-30
Summary
This study will analyze survival and outcome of patients with severe haemophilia who undergo liver transplantation in Spain
Conditions
- Hemophilia
- Hemophilia B
Interventions
- OTHER
-
Epidemiological Non interventional
Epidemiological Non interventional
Sponsors & Collaborators
-
Wyeth is now a wholly owned subsidiary of Pfizer
lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
More Related Trials
-
Liver Biopsy In Haemophilia Gene Therapy
NCT04817462 ·Status: RECRUITING ·Phase: NA
-
Transcultural Multidisciplinary Evaluation of Patients With Hemophili
NCT02199639 ·Status: UNKNOWN
-
Project to Update the Study of Congenital Haemophilia in Spain
NCT01959555 ·Status: COMPLETED
-
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
NCT05568719 ·Status: RECRUITING ·Phase: PHASE3
-
A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B
NCT02053792 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B
NCT00979238 ·Status: COMPLETED ·Phase: PHASE1
-
2-cohort Study of Adult Patients With Severe Hemophilia A in Greece
NCT02319070 ·Status: COMPLETED
-
Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America
NCT00969319 ·Status: COMPLETED
-
Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.
NCT04405518 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery
NCT00243659 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Hemophilia A Patients With FVIII Inhibitors
NCT04023019 ·Status: RECRUITING
-
A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B
NCT01496274 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Gene Therapy Study for Hemophilia B
NCT02484092 ·Status: COMPLETED ·Phase: PHASE2
-
TFPI Levels in Haemophilia A and B Patients
NCT04570696 ·Status: UNKNOWN
-
Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures
NCT01913405 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A
NCT01029340 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical and Health-related Outcome of rFVIIIFc Prophylaxis
NCT04583930 ·Status: UNKNOWN
-
Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia
NCT01285089 ·Status: COMPLETED
-
Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
NCT02971969 ·Status: COMPLETED
-
A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.
NCT02250560 ·Status: COMPLETED ·Phase: PHASE3
-
Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery
NCT00922597 ·Status: COMPLETED
-
Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors
NCT02020369 ·Status: COMPLETED ·Phase: PHASE3
-
A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI
NCT02207894 ·Status: RECRUITING
-
Multidisciplinary Evaluation of Patients With Hemophilia
NCT02198430 ·Status: COMPLETED
-
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
NCT01580293 ·Status: COMPLETED ·Phase: PHASE2/PHASE3